Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E

Free Radical Biology & Medicine
Kamesh AyasollaI Singh

Abstract

To investigate the putative role of beta-amyloid peptide (A beta) in inducing oxidative stress damage in Alzheimer disease (AD), we studied the effects of proinflammatory cytokines and A beta peptide on the induction of inducible nitric oxide synthase (iNOS). A beta(25-35) upregulated the cytokine (TNF-alpha/IL-1 beta)-induced expression of iNOS and the production of nitric oxide (NO) in astrocytes, which were inhibited by vitamin E. A beta treatment of C6 glial cells (together with LPS and IFN-gamma), in addition to inducing iNOS, enhanced the oxidative stress as measured by increased expression of manganese superoxide dismutase and an increase in 2,7'-dichlorofluorescein diacetate fluorescence. We also observed that LPS, IFN-gamma, and A beta(25-35) treatment led to the activation of the sphingomyelin-ceramide (SM-Cer) cascade with an increase in cellular ceramide. Inhibition of the SM-Cer cascade either by vitamin E treatment or by the neutral sphingomyelinase inhibitor 3-O-methyl sphingomyelin also resulted in alteration of the transcriptional binding activities of C/EBP, NFkappaB, AP-1, and CREB in C6 glial cells. Hence, these findings suggest a role for ceramide in iNOS induction and NO production in Abeta-induced AD path...Continue Reading

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S A FrautschyG M Cole
Apr 1, 1991·The American Journal of Clinical Nutrition·L Packer
Feb 1, 1994·Journal of Neurochemistry·D L FeinsteinD J Reis
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M HaraF Tamanoi
Feb 1, 1996·Journal of Neurochemistry·B BruggM Ruberg
May 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C K Sen, L Packer
Apr 1, 1996·Glycoconjugate Journal·D A Wiesner, G Dawson
Jul 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·V MansatJ P Jaffrézou
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·K T AkamaL J Van Eldik
Dec 22, 1999·Proceedings of the Society for Experimental Biology and Medicine·R A Floyd
Feb 1, 2000·Trends in Cell Biology·Y A Hannun, C Luberto
Feb 19, 2000·The American Journal of Clinical Nutrition·M Grundman
Aug 31, 2000·Neurobiology of Disease·B BreraM L de Ceballos
Oct 10, 2001·Journal of Neuroscience Research·Y LiW S Griffin
Dec 26, 2001·Journal of Neuroscience Research·Maria Luisa Cotrina, Maiken Nedergaard
Feb 6, 2002·Chembiochem : a European Journal of Chemical Biology·C ArenzA Giannis
Apr 9, 2002·Molecular and Cellular Biochemistry·Hee-Jung Kim, Kong-Joo Lee
Apr 30, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shailendra GiriAvtar K Singh
May 16, 2002·The Journal of Biological Chemistry·Yusuf A Hannun, Lina M Obeid
May 23, 2002·FEBS Letters·Angelo AzziJean Marc Zingg
Jun 6, 2002·The Journal of Biological Chemistry·William L Smith, Alfred H Merrill
Jul 11, 2002·Free Radical Biology & Medicine·Christian Behl, Bernd Moosmann
Sep 19, 2002·International Journal of Cancer. Journal International Du Cancer·Claire Rodriguez-LafrasseRobert Rousson
Mar 22, 2003·The Journal of Biological Chemistry·Luigi PuglielliDora M Kovacs

❮ Previous
Next ❯

Citations

Oct 9, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Pooja SrivastavaKaruna Shanker
Oct 30, 2009·Journal of Neural Transmission·Hans-Willi ClementErnst von Dobschütz
Nov 10, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Norman J HaugheyVeera Venkata Ratnam Bandaru
Jun 15, 2006·Antioxidants & Redox Signaling·Ramendra N Saha, Kalipada Pahan
Apr 2, 2011·Antioxidants & Redox Signaling·Mariana N Nikolova-Karakashian, Michael B Reid
Aug 19, 2007·Journal of Lipid Research·Kristina RutkuteMariana N Nikolova-Karakashian
Sep 4, 2013·The Journal of Endocrinology·Christian Hölscher
Aug 13, 2013·The International Journal of Neuroscience·Zhiyou CaiLiang-Jun Yan
Mar 5, 2016·Pharmacological Reports : PR·Kamil BieniasHalina Car
Dec 18, 2007·Journal of Neurochemistry·Je-Seong WonInderjit Singh
May 11, 2005·Biochemical and Biophysical Research Communications·Jung-Hee Jang, Young-Joon Surh
Apr 11, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Zeynab KolahdoozLeila Dargahi
Apr 15, 2011·Journal of Lipids·Susana J PasquaréNorma M Giusto
Jan 2, 2013·European Journal of Pharmacology·Vadivel Parthsarathy, Christian Hölscher
Jun 13, 2008·Neurobiology of Aging·Xingxuan HeEdward H Schuchman
Mar 8, 2005·Free Radical Biology & Medicine·Tzyh-Chwen JuDing-I Yang
May 24, 2006·Free Radical Biology & Medicine·Je-Seong Won, Inderjit Singh
Oct 22, 2008·Journal of Cellular Physiology·Chih-Chiang ChienYen-Chou Chen
Mar 20, 2010·Journal of Neurochemistry·Chiara MencarelliPilar Martínez-Martínez
Sep 9, 2011·Neuromolecular Medicine·Zhiyou CaiAnna Ratka
May 19, 2012·Journal of Physics. Condensed Matter : an Institute of Physics Journal·M Di CarloP L San Biagio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.